Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

MAD for Cancer recently recieved $2 million

Sven Påhlman and MAD for Cancer recently recieved $2 million aiming to support Sven´s research for improving outcome for neuroendocrine cancers.
MAD for Cancer paraganglioma
Micrograph of a carotid body in paraganglioma (Credits: Nephron, Wikimedia Commons)

A paraganglioma is a neuroendocrine type of tumor. It can develop at various body sites (including the head, neck, thorax and abdomen). The funding recieved by MAD for Cancer, in collaboration with Sven Påhlman, is aimed to support research in paraganglioma. More information about Sven Påhlman´s research can be found here.

Latest articles

18/09/2017
Lunds Fernströmpris till forskning om cancercellers samspel med omgivningen
Lunds Fernströmpris till forskning om cancercellers samspel med omgivningen
29/08/2017
Improved gene analysis of kidney cancer defines kidney cancer subtypes
Improved gene analysis of kidney cancer defines kidney cancer subtypes
13/06/2016
New variants of blood cancer in children
New variants of blood cancer in children
04/05/2016
A breakthrough of professor Kristian Pietras highlighted by Cancerfonden
A breakthrough of professor Kristian Pietras highlighted by Cancerfonden
08/04/2016
CREATE Health research in "Cancerfondsrapporten 2016"
CREATE Health research in "Cancerfondsrapporten 2016"